Jun O. Liu
Department of Pharmacology and Molecular Sciences
Johns Hopkins School of Medicine
725 N Wolfe St
Hunterian Building 516
Name/email consistency: high
- Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir. Shim, J.S., Rao, R., Beebe, K., Neckers, L., Han, I., Nahta, R., Liu, J.O. J. Natl. Cancer Inst. (2012)
- A calcineurin-independent mechanism of angiogenesis inhibition by a nonimmunosuppressive cyclosporin a analog. Nacev, B.A., Low, W.K., Huang, Z., Su, T.T., Su, Z., Alkuraya, H., Kasuga, D., Sun, W., Träger, M., Braun, M., Fischer, G., Zhang, K., Liu, J.O. J. Pharmacol. Exp. Ther. (2011)
- Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation. Liu, J.O. Immunol. Rev. (2009)
- It takes two binding sites for calcineurin and NFAT to tango. Liu, J.O., Nacev, B.A., Xu, J., Bhat, S. Mol. Cell (2009)
- The yins of T cell activation. Liu, J.O. Sci. STKE (2005)
- Endogenous protein inhibitors of calcineurin. Liu, J.O. Biochem. Biophys. Res. Commun. (2003)